(Q46334552)

English

Relative effects of telmisartan, candesartan and losartan on alleviating arterial stiffness in patients with hypertension complicated by diabetes mellitus: an evaluation using the cardio-ankle vascular index (CAVI).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

Relative effects of telmisartan, candesartan and losartan on alleviating arterial stiffness in patients with hypertension complicated by diabetes mellitus: an evaluation using the cardio-ankle vascular index (CAVI). (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

1 reference

based on heuristic

inferred from title

author name string

G Uehara

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

H Takeda

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

publication date

1 September 2008

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

Journal of International Medical Research

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

36

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

5

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

1094-1102

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Role of glycation in aging

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Significance of the vascular renin-angiotensin pathway

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Effects of mitogen-activated protein kinase pathway and co-activator CREP-binding protein on peroxisome proliferator-activated receptor-gamma-mediated transcription suppression of angiotensin II type 1 receptor gene

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Noninvasive assessment of arterial stiffness and risk of atherosclerotic events

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies.

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

[Effects of age on the relationship between cardio-ankle vascular index and atherosclerotic progression in patients with type 2 diabetes mellitus].

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI).

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Effects of telmisartan on arterial stiffness in Type 2 diabetes patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1177%2F147323000803600529

21 January 2018

Identifiers

10.1177/147323000803600529

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/18831906

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46334552&oldid=1582910751"